All statements about the relative importance of WHO should be involved in identifying potential consequences, prioritising which consequences to systematically evaluate, undertaking appropriate evaluation and interpreting the data
| Identifying potential consequences | Prioritising which consequences to systematically evaluate | Undertaking appropriate evaluation | Interpreting the data | |||||
| % rating very or extremely important | Mean rating* | % rating very or extremely important | Mean rating* | % rating very or extremely important | Mean rating* | % rating very or extremely important | Mean rating* | |
| Clinical teams delivering the targeted care (clinicians and non-clinicians who directly engage with patients in the targeted area) | 100† | 4.80† | 96† | 4.75† | 91† | 4.60† | 86† | 4.48† |
| Managerial staff involved in organising the targeted care | 80† | 4.22† | 83† | 4.25† | 75 | 4.12 | 78 | 4.18 |
| Patients or carers | 83† | 4.21† | 70 | 3.98 | 58 | 3.61 | 56 | 3.70 |
| Clinical teams outside the targeted area of improvement who directly engage with patients | 66 | 3.73 | 55 | 3.55 | 48 | 3.35 | 40 | 3.28 |
| Improvement advisors (people with healthcare improvement expertise external to the local clinical and managerial teams | 61 | 3.86 | 71 | 3.95 | 73 | 4.00 | 91† | 4.30† |
| Third sector (eg, voluntary and community organisations, charities or social enterprises) | 50 | 3.42 | 18 | 3.40 | 36 | 3.01 | 38 | 3.15 |
| Academics (people with relevant expertise with a university or similar academic base and perspective) | 46 | 3.36 | 53 | 3.48 | 38 | 3.15 | 73 | 3.93 |
| Policy-makers and regulators | 46 | 3.33 | 48 | 3.33 | 40 | 3.01 | 56 | 3.45 |
*1=not at all important, 2=slightly important, 3=somewhat important, 4=very important, 5=extremely important.
†Indicates consensus among panellists meaning that ≥80% of participants rated a statement as very important and extremely important.